C J Koch|S M Evans|E M Lord - JoVE Visualize

Showing results (1-10 of 334) with videos related to

Pageof 34

Sort By:

British Journal of Cancer|October 1, 1995

Oxygen dependence of cellular uptake of EF5 [2-(2-nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl)a cet amide] : analysis of drug adducts by fluorescent antibodies vs bound radioactivityC J Koch, S M Evans, E M Lord

Cancer Research|January 15, 1996

2-Nitroimidazole (EF5) binding predicts radiation resistance in individual 9L s.c. tumorsS M Evans, W T Jenkins, B Joiner, et al.

The American Journal of Physiology|April 1, 1997

Chondrocytes in the endochondral growth cartilage are not hypoxicI M Shapiro, K D Mansfield, S M Evans, et al.

Neuroscience|June 11, 1999

Detection of hypoxic cells with the 2-nitroimidazole, EF5, correlates with early redox changes in rat brain after perinatal hypoxia-ischemiaM Bergeron, S M Evans, F R Sharp, et al.

British Journal of Cancer|October 1, 1995

Identification of hypoxia in cells and tissues of epigastric 9L rat glioma using EF5 [2-(2-nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl) acetamide]S M Evans, B Joiner, W T Jenkins, et al.

Cancer Research|December 1, 1993

Detection of hypoxic cells by monoclonal antibody recognizing 2-nitroimidazole adductsE M Lord, L Harwell, C J Koch

International Journal of Cancer|September 4, 1996

Cysteine concentrations in rodent tumors: unexpectedly high values may cause therapy resistanceC J Koch, S M Evans

The Journal of Pharmacology and Experimental Therapeutics|May 1, 1996

Biodistribution of the nitroimidazole EF5 (2-[2-nitro-1H-imidazol-1-yl]-N-(2,2,3,3,3-pentafluoropropyl) acetamide) in mice bearing subcutaneous EMT6 tumorsK M Laughlin, S M Evans, W T Jenkins, et al.

International Journal of Radiation Oncology, Biology, Physics|January 1, 1996

Detection of individual hypoxic cells in multicellular spheroids by flow cytometry using the 2-nitroimidazole, EF5, and monoclonal antibodiesM L Woods, C J Koch, E M Lord

International Journal of Cancer|July 29, 1996

Direct relationship between radiobiological hypoxia in tumors and monoclonal antibody detection of EF5 cellular adductsJ Lee, D W Siemann, C J Koch, et al.

Pageof 34

Showing results (1-10 of 334) with videos related to

Sort By:

Pageof 34

British Journal of Cancer|October 1, 1995

Oxygen dependence of cellular uptake of EF5 [2-(2-nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl)a cet amide] : analysis of drug adducts by fluorescent antibodies vs bound radioactivityC J Koch, S M Evans, E M Lord

Cancer Research|January 15, 1996

2-Nitroimidazole (EF5) binding predicts radiation resistance in individual 9L s.c. tumorsS M Evans, W T Jenkins, B Joiner, et al.

The American Journal of Physiology|April 1, 1997

Chondrocytes in the endochondral growth cartilage are not hypoxicI M Shapiro, K D Mansfield, S M Evans, et al.

Neuroscience|June 11, 1999

Detection of hypoxic cells with the 2-nitroimidazole, EF5, correlates with early redox changes in rat brain after perinatal hypoxia-ischemiaM Bergeron, S M Evans, F R Sharp, et al.

British Journal of Cancer|October 1, 1995

Identification of hypoxia in cells and tissues of epigastric 9L rat glioma using EF5 [2-(2-nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl) acetamide]S M Evans, B Joiner, W T Jenkins, et al.

Cancer Research|December 1, 1993

Detection of hypoxic cells by monoclonal antibody recognizing 2-nitroimidazole adductsE M Lord, L Harwell, C J Koch

International Journal of Cancer|September 4, 1996

Cysteine concentrations in rodent tumors: unexpectedly high values may cause therapy resistanceC J Koch, S M Evans

The Journal of Pharmacology and Experimental Therapeutics|May 1, 1996

Biodistribution of the nitroimidazole EF5 (2-[2-nitro-1H-imidazol-1-yl]-N-(2,2,3,3,3-pentafluoropropyl) acetamide) in mice bearing subcutaneous EMT6 tumorsK M Laughlin, S M Evans, W T Jenkins, et al.

International Journal of Radiation Oncology, Biology, Physics|January 1, 1996

Detection of individual hypoxic cells in multicellular spheroids by flow cytometry using the 2-nitroimidazole, EF5, and monoclonal antibodiesM L Woods, C J Koch, E M Lord

International Journal of Cancer|July 29, 1996

Direct relationship between radiobiological hypoxia in tumors and monoclonal antibody detection of EF5 cellular adductsJ Lee, D W Siemann, C J Koch, et al.

Pageof 34